Key result
Hydroquinidine may rescue arrhythmic storm in patients with ICM and severely impaired LVEF.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
May support rescue consideration in refractory cases; hypothesis-generating and requires prospective trials.
International audience
No takes yet. Share an insight, caveat, or question.
Hanquiez et al. (2024) studied this question. Hydroquinidine may serve as a rescue therapy for arrhythmic storm in patients with ischemic cardiomyopathy and severely impaired left ventricular ejection fraction.
Synapse has enriched 10 related papers. Consider them for comparative context: